Trump's desperate hours: He was contemptuous of the virus

New Post Public Reply Private Reply Replies (2) Message Board
Bhawks
313
Trump's desperate hours: He was contemptuous of the virus — now it has him trapped

Trump was convinced COVID-19 was nothing — and now it's in the White House. He's a desperate, dangerous man

Lucian K. Truscott IV

May 9, 2020 12:00PM (UTC)

Imagine you're dreaming, and it's a really, really bad dream. It's night, and something is chasing you down a dark street. You're running and running and running, trying to get away. All the windows are dark. No lights are on in any of the houses and apartments along the street. You bang on doors, but no one answers. You try the door handles, but the doors are all locked. When you cry out for help, no words come out of your mouth. No one can hear you. You keep running and running and running…

This is why Donald Trump is awake at 2:30 a.m., rage-tweeting. When he sleeps, he dreams, and his dreams are nightmares. He's a frightened, desperate man. Every day, he turns on his television, and the death count from the COVID-19 virus keeps going up. The economy — the precious economy, the one he's so proud of for no particular reason — is tanking. His poll numbers are down. His approval ratings are down. He's losing to Joe Biden in national polls and in every important swing state. Nothing he does is helping.

He has tried everything to beat the virus. First he denied it was a problem. You remember the quotes from February and March: It's only a few cases. Like magic, it will just go away. Then his people convinced him it wasn't going away, and he had to do something. So he trotted out a string of corporate execs and golf buddies onto a stage in the Rose Garden and declared a national emergency. Surely that would fix things!

But the virus kept spreading, and people were dying. The NBA canceled its season. So did Major League Baseball and NASCAR. Businesses started closing … General Motors, Ford, big businesses — and then small businesses like restaurants and retail stores and salons and barber shops . Unemployment numbers skyrocketed. Six million. Then another five million. Another six million. And those were just the people out of work who actually applied for unemployment benefits.

The virus kept spreading, and people kept dying. Trump called together a "task force" to confront the problem, and he put his vice president in charge. So Mike Pence started holding briefings in the White House press room with input from experts like Dr. Anthony Fauci and Dr. Deborah Birx, the one with the shoulder scarves. When all the networks started covering them and the ratings were through the roof, Trump took over the briefings himself.

But things kept getting worse. The virus was everywhere. Hospitals were running out of protective gear like gowns and masks, emergency rooms were overrun, there was a shortage of ventilators. They had to do something, so they printed up a bunch of cards with "guidelines" for something called social distancing that was supposed to last 15 days.

Then Congress got involved and passed some emergency bills. First it was in the billions, then it was in the trillions. Small business loans, hundreds of billions — gone in a matter of days. And still the unemployment numbers went up.

Then they hit the end of the 15 days, and the death count kept going up, so they extended the "guidelines," and he started pushing a cure his pals were talking about on Fox, some malaria drug called hydroxychloroquine. "What have you got to lose?" he crowed from the podium at the briefings.


Apparently, a lot. People started dying from the hydroxychloroquine, something to do with their hearts. So he stopped pushing the pill, and he pivoted to "opening up" the economy.

Away went the "guidelines," and up popped the tweets: LIBERATE Michigan! LIBERATE Virginia! Let's get those businesses up and running! He put out new "guidelines" for opening up the economy. Three phases! Real simple! Just get your numbers of new cases down for 14 days, and everything can start getting back to normal!

About half the states announced relaxation of rules, and businesses began to reopen. But the virus kept spreading. Now it was in rural Georgia and Arkansas and Iowa, all those precious red states he could point to that were "doing things right," that didn't need to be "bailed out" like "Democrat states."

The death count kept increasing, and some idiot in the CDC came up with the theory that sunlight and ultraviolet rays could kill the virus. Bleach and other disinfectants definitely killed it (on countertops, that is), so Trump pushed the "light" and the disinfectants "inside" and his whole house of cards fell apart.

They were making fun of him! All those pundits and newspapers and networks he had been having so much fun yelling at during the briefings … they were laughing at him! So he decided he'd show them! He canceled a few briefings, then he showed up for one and walked out after a few minutes. Then he decided he would announce that he was phasing out the "task force."

A day later, he was back in front of the cameras saying he hadn't realized how "popular" the task force was, so of course he'd keep it going — not because the task force was accomplishing anything, but because it was "popular."

But behind the scenes, Trump was getting briefings. Terrible briefings. Really awful stuff. His own campaign manager, Brad Parscale, who was reported to have spent his hefty paycheck from the Trump campaign on condos, a luxury boat and a Ferrari, met with him and showed him his internal poll numbers.

They were terrible — worse than the public numbers according to some reports. He blew up at Parscale. He was in a rage, screaming at the poor guy at the top of his lungs. All the stuff he'd been doing — all the briefings, all the guidelines, all the trillions in relief money, all the magic cures — and look where it got him! Nowhere!


This week came the private briefings on the economy. They were terrible, according to NBC News. "Some of the projections showed the unemployment rate skyrocketing above 30 percent and the widespread collapse of small businesses, according to multiple people familiar with the briefings." One projection had more than 50 percent of American small businesses collapsing if the country did not get back to work.

"The projections have infuriated Trump," one source told NBC. "He lost it."

He must have "lost it" again on Friday morning when it was announced that unemployment in April hit 14.7 percent. "I think the real number is probably around 23 or 24 percent. It's devastating," said Neal Kashkari, president of the Federal Reserve Bank of Minneapolis, on the "Today" show.


Trump got away from the White House for the first time this week, traveling to Arizona (a state where his numbers aren't where he wants them to be) to visit a factory that makes face masks. Hovering over a worker wearing a mask who was making masks, Trump didn't wear one. Aides later explained he thought he would look "weak" and "ridiculous" in a face mask.

By Thursday, it was revealed that one of Trump's valets had tested positive for the virus. This is the person who serves Trump his meals and brings him his Diet Cokes. On Friday, we learned that Katie Miller, an aide to Vice President Pence — who is married to Stephen Miller, Trump's most nefarious adviser — had tested positive for the virus. Pence was conspicuously unmasked last week during a visit to the Mayo Clinic in Minnesota, flouting the clinic's rule that everyone wear masks.

Donald Trump has consistently shown contempt for the coronavirus. Now the virus, which has infected 1.3 million people in this country and killed more than 78,000, has made its way into the White House.

Experts were saying on Friday that the virus has probably spread completely through the West Wing. Of course it has. Sources told MSNBC that "no one" in the White House has been observing social distance rules or wearing masks.

Trump's arrogance and dithering and denial has cost tens of thousands of American lives and will cost tens of thousands, if not hundreds of thousands, more. He is the president, and he is supposedly in charge, and nothing he has done has worked.

His scattershot plan to "reopen" the economy won't save him. Blaming China or Barack Obama or Joe Biden or anyone else won't save him. He is a defeated, desperate man. We still have to vote in the election in November, but he has already lost.

The virus beat him.

Lucian K. Truscott IV

Lucian K. Truscott IV, a graduate of West Point, has had a 50-year career as a journalist, novelist and screenwriter. He has covered stories such as Watergate, the Stonewall riots and wars in Lebanon, Iraq and Afghanistan. He is also the author of five bestselling novels and several unsuccessful motion pictures.

He has three children, lives on the East End of Long Island and spends his time Worrying About the State of Our Nation and madly scribbling in a so-far fruitless attempt to Make Things Better. He can be followed on Facebook at The Rabbit Hole and on Twitter @LucianKTruscott.

https://www.salon.com/2020/05/09/trumps-despe...m-trapped/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

OSL Unveils Instant Redemption for USDGO Plus SP

Updated Category News Views 148

OSL's New Move: Instant Redemption on the Table Alright, let's chew over OSL's latest gambit—you know, those folks (HKEX: 863) who are knee-deep in the digital currency swamp. They've launched this "Instant Redemption" feature for these fancy real-world asset products, and USDGO Plus SP is right there at the forefront. Getting the Fine Print Straight Now, not just...

Continue Reading
PG&E, Edison Push Liability Cap Amid Firestorm

Updated Category News Views 152

The Thanksgiving Playbook Nobody Wanted Sacramento's corridors are buzzing with electric tension. And why? It's not some trivial turkey drama but a simmering scandal over two utility giants trying to sneak a liability cap into law faster than you can ask for a second slice of pumpkin pie. PG&E and Edison have a little secret—a covert strategy to limit shareholder...

Continue Reading
Montefiore Einstein Takes On Breast Cancer's Hidden Battle

Updated Category News Views 49

Call me old-fashioned, but when cancer whispers in the shadows even after it's supposedly signed off the death certificate, you're dealing with one heck of a slippery adversary. That's where Montefiore Einstein Comprehensive Cancer Center comes in, armed with ten million greenbacks from the National Cancer Institute, primed to rattle the labyrinth of breast cancer...

Continue Reading
Tulsa Hosts Gradient's Global Tech and Investment Event

Updated Category News Views 89

Tulsa's New Spotlight: Gradient's CHROMA Event Well, look at Tulsa, becoming the center of the tech and enterprise universe for a day. Gradient is throwing open the doors for its second annual CHROMA event on September 24, 2026. You might scratch your head and say, ‘Tulsa? Really?’ But hear me out—this isn’t just a local shindig. We're talking about a one-day...

Continue Reading
Minghui and ASKA Seal Major Licensing Deal for MHB018A

Updated Category News Views 164

Breaking New Ground in Thyroid Eye Disease Treatment If there's one thing that keeps the biopharma world on its toes, it's the relentless pursuit of groundbreaking treatments. And folks, let me tell you, the latest tie-up between Minghui Pharmaceutical and ASKA Pharmaceutical has struck a chord. This union with MHB018A at its core might be one of those watershed moments...

Continue Reading
Cloud Software Group Amends $2B Cash Tender Offer

Updated Category News Views 89

Cloud Software Group is stirring the pot with an amendment that'll have bondholders looking twice at their portfolios. On November 3, 2026, the company announced a tweak to its cash tender offer, bumping up the payment for its 9.00% Senior Secured Second Lien Notes due 2029. The payout now jumps from $1,017.50 to $1,022.50 for each $1,000 of principal. If you're holding...

Continue Reading
Japan's RWE Market Transformation: TXP's Insightful Whitepaper

Updated Category News Views 55

Unraveling the Real-World Evidence Landscape in Japan The folks at TXP Medical just dropped a bombshell of a whitepaper that'll have Medical Affairs departments buzzing. Imagine waking up to a market that's exploding by over 500% in just a decade—yeah, I'm talking about the EMR-derived data market in Japan. These guys are saying it's gonna shoot from ¥3.9 billion in...

Continue Reading
Hyundai Pushes Hydrogen Boundaries at 2026 Expo

Updated Category News Views 105

A Bold Step Into the Hydrogen Era Hyundai's really stepping it up at the World Hydrogen Expo 2026. They're not just dipping their toes in the hydrogen pool—they're diving in headfirst, showing off integrated hydrogen solutions that are nothing short of ambitious. Hydrogen Production That's a Real Game Changer This ain't just talk. Hyundai's showcasing modular PEM...

Continue Reading
Qapture's Institutional Stablecoin Venture Unveiled

Updated Category News Views 69

Stablecoin Strategy Meets Institutional Investment Here's a fresh one from the digital asset universe. We're talking about Qapture Investments' bold move to launch an institutional-grade stablecoin yield strategy. This ain't your average kitchen table crypto chat—it's the Qapture Safe Haven Vault (QHVN-USD), tailored for those looking to get a better return on their...

Continue Reading
Hormel Foods Sets Stage for Q4 Earnings Call in December

Updated Category News Views 124

Hormel Foods Prepares for Earnings Spotlight In a world where market instability feels like the only constant, Hormel Foods Corporation (NYSE:HRL) is setting up one of those must-watch moments. You've got DECEMBER 3rd circled on your cal, right? If not, you're about to miss a curtain raiser that could send ripples across portfolios. Setting the Stage: December's Big...

Continue Reading

Top 5 Most Recently Viewed Articles

KAYALI Unveils Irresistible Oudgasm Fragrances for All

Updated Category News Views 370

KAYALI Introduces Exciting New Fragrances KAYALI, the extraordinary fragrance house created by Mona Kattan, has once again captivated the world by expanding its popular Oudgasm Collection. The new scents include Oudgasm Chocolate Oud | 11 Eau de Parfum Intense and Oudgasm Milky Musk Oud | 30 Eau de Parfum Intense. These additions offer an innovative twist on oud, one of...

Continue Reading
Ingersoll Rand Announces Earnings Release and Call Details

Updated Category News Views 68

Ingersoll Rand Inc. (NYSE: IR) was gearing up to drop its third-quarter earnings in October 2024, and you know how these releases can shake the tree. With the market closing on a Thursday, traders were already calculating their bets ahead of this release—a classic pre-weekend play where anything could happen. What Traders Anticipated from Ingersoll Rand's Q3 Earnings...

Continue Reading
AppWork Secures Significant Funding to Enhance Operations

Updated Category News Views 218

AppWork Secures $13 Million in Series A Funding Investment will accelerate product development and customer success as AppWork scales its industry-leading platform AppWork, a fast-growing software platform designed to optimize maintenance operations for multifamily property management teams, has successfully secured $13 million in Series A funding. The investment was led...

Continue Reading
Mecho's Launch of EcoGlass Blackout Enhances Sustainability Efforts

Updated Category News Views 195

Mecho Enhances Sustainability with EcoGlass Blackout Mecho, a renowned leader in commercial shading solutions, has recently accomplished a significant sustainability milestone by introducing Environmental Product Declarations (EPDs) for its motorized shade systems, alongside its groundbreaking product EcoGlass Blackout. This innovative blackout fabric is the first of its...

Continue Reading
Vivoryon Therapeutics N.V. Prepares for Q1 2025 Financial Update

Updated Category News Views 318

Vivoryon Therapeutics N.V. Announces Q1 2025 Financial Results Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) is gearing up to unveil its financial results for the first quarter of 2025. This announcement is pivotal as it not only reflects the company's financial health but also signals its ongoing commitment to advancing treatments for inflammatory...

Continue Reading